GlassScriptPhysician profile
Cecilia Hernandez
NPI 1861019630
$6,124.28
in general payments reported to CMS, 2019-2025
14 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.97 · 2021: $16.40 · 2022: $768 · 2023: $2,263 · 2024: $2,796 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061 · Travel and Lodging: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,060.86 |
| Travel and Lodging | $1,239.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,796.55 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $1,191.68 | 2022-2025 | Clareon, Hydrus Microstent, Ngenuity |
| Abbvie INC. | $866.20 | 2022-2025 | |
| New World Medical,INC. | $800.39 | 2023 | |
| Bausch & Lomb Americas INC. | $458.83 | 2022-2024 | Envista Mx60 Iol, Stellaris |
| Carl Zeiss Meditec USA, INC. | $252.56 | 2023-2024 | Quatera 700, Forum |
| Johnson & Johnson Surgical Vision, INC. | $211.06 | 2023-2024 | Tecnis Iol |
| Genentech, INC. | $136.97 | 2023 | Vabysmo |
| Harrow Eye, LLC | $121.80 | 2024 | Tobradex St, Iheezo, Natacyn |
| Axogen | $121.30 | 2023 | Avance Nerve Graft |
| Horizon Therapeutics Plc | $111.57 | 2022 | |
| Biotissue Holdings INC. | $20.83 | 2020 | |
| Allergan, INC. | $18.14 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.